Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy with Radiotherapy-Erbitux in Locally Advanced HNSCC
NCT00609284Phase 3Completed
- Sponsor
- GORTEC
- Start
- Feb 2008
- Primary completion
- Mar 2018
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin, fluorouracil in head and neck squamous cell carcinoma (HNSCC), sponsored by GORTEC. Started Feb 2008; status: completed.
02
Drugs
carboplatinfluorouracil
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00609284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609284.